410 related articles for article (PubMed ID: 29439552)
1. Proteinaceous Regulators and Inhibitors of Protein Tyrosine Phosphatases.
Hendriks W; Bourgonje A; Leenders W; Pulido R
Molecules; 2018 Feb; 23(2):. PubMed ID: 29439552
[TBL] [Abstract][Full Text] [Related]
2. Drugging the Undruggable: Therapeutic Potential of Targeting Protein Tyrosine Phosphatases.
Zhang ZY
Acc Chem Res; 2017 Jan; 50(1):122-129. PubMed ID: 27977138
[TBL] [Abstract][Full Text] [Related]
3. Phosphoryltyrosyl mimetics in the design of peptide-based signal transduction inhibitors.
Burke TR; Yao ZJ; Liu DG; Voigt J; Gao Y
Biopolymers; 2001; 60(1):32-44. PubMed ID: 11376431
[TBL] [Abstract][Full Text] [Related]
4. Functional studies of protein tyrosine phosphatases with chemical approaches.
Zhang ZY
Biochim Biophys Acta; 2005 Dec; 1754(1-2):100-7. PubMed ID: 16226063
[TBL] [Abstract][Full Text] [Related]
5. Protein-tyrosine phosphatases: structure, mechanism, and inhibitor discovery.
Burke TR; Zhang ZY
Biopolymers; 1998; 47(3):225-41. PubMed ID: 9817026
[TBL] [Abstract][Full Text] [Related]
6. Generation of inhibitor-sensitive protein tyrosine phosphatases via active-site mutations.
Bishop AC; Zhang XY; Lone AM
Methods; 2007 Jul; 42(3):278-88. PubMed ID: 17532515
[TBL] [Abstract][Full Text] [Related]
7. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
Wang B; Lemay S; Tsai S; Veillette A
Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
[TBL] [Abstract][Full Text] [Related]
8. Peptidomimetic competitive inhibitors of protein tyrosine phosphatases.
Shen K; Qi L; Stiff L
Curr Pharm Des; 2010; 16(28):3101-17. PubMed ID: 20687872
[TBL] [Abstract][Full Text] [Related]
9. Use of Dominant-Negative/Substrate Trapping PTP Mutations to Search for PTP Interactors/Substrates.
Radha V
Methods Mol Biol; 2016; 1447():243-65. PubMed ID: 27514810
[TBL] [Abstract][Full Text] [Related]
10. Functional interrogation and therapeutic targeting of protein tyrosine phosphatases.
Krabill AD; Zhang ZY
Biochem Soc Trans; 2021 Aug; 49(4):1723-1734. PubMed ID: 34431504
[TBL] [Abstract][Full Text] [Related]
11. PTP-SL and STEP protein tyrosine phosphatases regulate the activation of the extracellular signal-regulated kinases ERK1 and ERK2 by association through a kinase interaction motif.
Pulido R; Zúñiga A; Ullrich A
EMBO J; 1998 Dec; 17(24):7337-50. PubMed ID: 9857190
[TBL] [Abstract][Full Text] [Related]
12. Possible involvement of a tyrosine kinase-dependent pathway in the regulation of phosphoinositide metabolism by vanadate in normal mouse islets.
Jonas JC; Henquin JC
Biochem J; 1996 Apr; 315 ( Pt 1)(Pt 1):49-55. PubMed ID: 8670131
[TBL] [Abstract][Full Text] [Related]
13. Inhibitors of protein tyrosine phosphatases: next-generation drugs?
Bialy L; Waldmann H
Angew Chem Int Ed Engl; 2005 Jun; 44(25):3814-39. PubMed ID: 15900534
[TBL] [Abstract][Full Text] [Related]
14. Impact of oncogenic protein tyrosine phosphatases in cancer.
Hardy S; Julien SG; Tremblay ML
Anticancer Agents Med Chem; 2012 Jan; 12(1):4-18. PubMed ID: 21707506
[TBL] [Abstract][Full Text] [Related]
15. Bidentate inhibitors of protein tyrosine phosphatases.
Low JL; Chai CL; Yao SQ
Antioxid Redox Signal; 2014 May; 20(14):2225-50. PubMed ID: 24206395
[TBL] [Abstract][Full Text] [Related]
16. Allele-specific inhibitors of protein tyrosine phosphatases.
Hoffman HE; Blair ER; Johndrow JE; Bishop AC
J Am Chem Soc; 2005 Mar; 127(9):2824-5. PubMed ID: 15740097
[TBL] [Abstract][Full Text] [Related]
17. Targeting Tyrosine Phosphatases: Time to End the Stigma.
Stanford SM; Bottini N
Trends Pharmacol Sci; 2017 Jun; 38(6):524-540. PubMed ID: 28412041
[TBL] [Abstract][Full Text] [Related]
18. Chemical and mechanistic approaches to the study of protein tyrosine phosphatases.
Zhang ZY
Acc Chem Res; 2003 Jun; 36(6):385-92. PubMed ID: 12809524
[TBL] [Abstract][Full Text] [Related]
19. Development of Novel Phosphonodifluoromethyl-Containing Phosphotyrosine Mimetics and a First-In-Class, Potent, Selective, and Bioavailable Inhibitor of Human CDC14 Phosphatases.
Dong J; Jassim BA; Milholland KL; Qu Z; Bai Y; Miao Y; Miao J; Ma Y; Lin J; Hall MC; Zhang ZY
J Med Chem; 2024 Jun; 67(11):8817-8835. PubMed ID: 38768084
[TBL] [Abstract][Full Text] [Related]
20. Transfection of human ovarian cancer cells with the HER-2/neu receptor tyrosine kinase induces a selective increase in PTP-H1, PTP-1B, PTP-alpha expression.
Wiener JR; Kassim SK; Yu Y; Mills GB; Bast RC
Gynecol Oncol; 1996 May; 61(2):233-40. PubMed ID: 8626139
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
